Condensed Statements of Cash Flows - USD ($)	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (397,508)	$ (616,728)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	162,035	195,361
Share-based compensation expense	37,595	29,936
Provision for doubtful accounts, net	(500)
Provision for inventory obsolescence, net	22,000	86,501
Change in operating assets and liabilities:
Accounts receivable	95,082	73,019
Inventories	341,457	20,636
Prepaid expenses and other assets	(10,386)	(143,502)
Accounts payable	(211,663)	(121,296)
Accrued compensation and other accrued liabilities	(98,009)	(126,664)
Net cash (used in) operating activities	(59,897)	(602,737)
Cash flows from investing activities:
Acquisition of property and equipment	(10,985)	(21,918)
Patent costs	(10,581)	(26,030)
Net cash (used in) investing activities	(21,566)	(47,948)
Cash flows from financing activities:
Paydown of credit facility	(64,000)
Net cash provided by financing activities	(64,000)
Net decrease in cash and cash equivalents	(145,463)	(650,685)
Cash and cash equivalents, beginning of period	258,656	1,689,580
Cash and cash equivalents, end of period	$ 113,193	$ 1,038,895